Exenatide Compared With Twice-Daily Biphasic Insulin Aspart in Patients With Type 2 Diabetes Using Sulfonylurea and Metformin

This study has been completed.

Study NCT00082407 Information provided by Amylin Pharmaceuticals, Inc.

First Received: May 6, 2004 Last Updated: November 5, 2007 History of Changes

No Study Results Posted for this Study

Study Status:	This study has been completed.
Estimated Study Completion Date:	No date given
Estimated Primary Completion Date:	No date given